Monday, August 31, 2026 Never miss a recall or a rule change Get the free brief →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
Devices & TechSofwave Hits One Million TreatmentstodayComplianceWarning: New York Man Arrested for Injecting Counterfeit Botox2 days agoSearch DemandWho Can Inject Botox and Filler in Florida: Scope of Practice and Licensure RequirementstodayDevices & TechBODYWELLE Brings EMSculpt NEO to Miami Beach2 days agoSearch DemandMedical Spa Revenue Calculator: Model Your Practice EconomicstodayDevices & TechCytrellis Launches Full-Body Resurfacing in Australia2 days agoSearch DemandGood Faith Exam for Med Spas: State Requirements, Scope, and CompliancetodayInjectablesRHA Redensity Eye Clears FDA for Undereye Hollowing2 days agoBusiness & M&AGalderma Opens Miami HQ for U.S., LATAM PushtodayMarketGLP-1 Weight Loss Drives Full-Body Cosmetic DemandyesterdayBusiness & M&AEvolus Beats EPS Forecast; Stock Rallies 2.22%yesterdayBusiness & M&AALEXIS LAUREN Medspa Targets Nashville Expansionyesterday
Business & M&A

InMode Guides Q2 2026 Revenue to $95.2M–$95.4M, Reiterates $365M–$375M Full-Year Target

InMode's Q2 beat and full-year guidance hold steady despite acquisition uncertainty.

Image: Inside MedSpa
1-YEAR MOVE
+3% −14%
INMD ▲1.0%
1-year price move by ticker
TickerCompany1-year change
INMDInMode Ltd.+1.0%

InMode has guided Q2 2026 revenue to $95.2–$95.4 million and reiterated full-year 2026 guidance of $365–$375 million, representing mid-to-high single-digit growth. The Q2 guidance sits above consensus expectations, suggesting continued demand for the company's RF, laser, and energy-device portfolio across geographies.

InMode guides Q2 2026 revenue to $95.2–$95.4 million, beating consensus and reiterating full-year guidance of $365–$375 million.

The steady guidance amid the Steel Partners takeover proposal underscores InMode's operational resilience. For practice owners, the message is clear: device revenue is holding despite macro uncertainty. The $365–$375 million full-year range implies Q3–Q4 sequential growth, likely driven by seasonal demand for skin-tightening and resurfacing procedures in the Northern Hemisphere fall/winter. However, the pending acquisition creates a cloud over long-term roadmap visibility and pricing strategy. Owners should monitor August 5 earnings for commentary on competitive positioning and international expansion—areas that could shift under new ownership.

Source: original report ↗

Frequently asked questions

What is InMode's Q2 2026 revenue guidance?

InMode has guided Q2 2026 revenue to $95.2–$95.4 million, which sits above consensus expectations and reflects mid-to-high single-digit growth. This guidance signals continued strong demand for the company's RF, laser, and energy-device portfolio across geographies.

What is InMode's full-year 2026 revenue target?

InMode has reiterated full-year 2026 guidance of $365–$375 million, representing mid-to-high single-digit growth. This range implies sequential growth in Q3–Q4, likely driven by seasonal demand for skin-tightening and resurfacing procedures in the Northern Hemisphere fall and winter.

How is the Steel Partners acquisition affecting InMode's business outlook?

The pending Steel Partners takeover creates uncertainty around long-term roadmap visibility and pricing strategy, though InMode's steady guidance demonstrates operational resilience. Practice owners should monitor the August 5 earnings call for commentary on competitive positioning and international expansion, as these areas could shift under new ownership.

Why is InMode's Q2 guidance significant for med spa owners?

The Q2 beat above consensus expectations indicates device revenue is holding strong despite macro uncertainty and acquisition clouds. This suggests continued market demand for RF, laser, and energy-based treatments, providing confidence for practices planning capital equipment investments.

When should med spa owners expect seasonal demand peaks for InMode devices?

InMode's Q3–Q4 guidance implies seasonal demand peaks in the Northern Hemisphere fall and winter months, driven by increased patient interest in skin-tightening and resurfacing procedures. Practice owners should plan inventory and marketing accordingly for these higher-demand periods.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $20/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://insidemedspa.com/article/inmode-q2-2026-revenue-guidance-95-2-95-4-million/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa Pro

    By the time it's news, it's too late.

    The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

    Get the free brief Never miss a recall or a rule change. Cancel anytime.
    The twice-a-week intelligence brief Get the free brief